Slager David Mark 13D and 13G filings for Oramed Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-09 3:52 pm Purchase |
2020-12-31 | 13G | Oramed Pharmaceuticals Inc. ORMP |
Slager David Mark | 1,344,123 5.040% |
27,800 (+2.11%) |
Filing |